AR and metabolic dysfunction-associated steatohepatitis: Interestingly, an androgen receptor (AR)-driven oncogene named cell cycle-related kinase (CCRK) contributes to obesity-induced pro-inflammatory signaling, inducing the development of NASH-related hepatocarcinogenesis.